PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
CompletedNot applicableNCT05036499
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
There is a pressing public health need to develop novel interventions that aim to reduce alcohol consumption and concurrent alcohol among hazardous drinkers with comorbid chronic pain. The proposed study will draw upon NIH treatment development guidelines (Stage 1) to translate and innovate past work to address a major public health priority. Specifically, we propose to develop (Phase IA) and pilot test (Phase IB) a brief, integrated, single-session, computer-based personalized feedback intervention (PFI) designed to 1) enhance knowledge regarding adverse pain-related anxiety-alcohol interrelations; and (2) increase motivation and intention to reduce hazardous drinking.
Study details
- Official title
- Development of a Personalized Feedback Intervention Targeting Pain-Related Anxiety for Hazardous Drinkers With Chronic Pain
- Conditions
- Alcohol Problem
- Chronic Pain
- Alcohol Abuse
- Interventions
- Behavioral: Personalized Feedback Intervention
- Sponsor
- University of Houston
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Start date
- 2021-09-27
- Primary completion
- 2023-03-15
- Sex
- All
- Age range
- from 21 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ≥ 21 years of age * Current hazardous drinking pattern (AUDIT scores ≥ 8 for males and ≥ 7 for females) * Current chronic pain (1) on most days of the week (i.e., 4 or more days per week), (2) at an average weekly severity of 3 or greater on a 0-10 numerical rating scale, and (3) for at least three months in duration * Fluent in English Exclusion Criteria: 1. Concurrent alcohol or other substance use treatment 2. Not being fluent in English 3. Current acute psychiatric distress or thought disorder 4. Current imminent risk of suicidality
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05036499